97 results
Page 3 of 5
8-K
fqoy29
7 Apr 20
Departure of Directors or Certain Officers
8:01am
8-K
EX-10.1
n9b8du4v03
12 Mar 20
Sientra Announces $60 Million Convertible Notes Investment from
4:40pm
8-K
EX-99.1
oam91fu hot
13 Jan 20
Sientra Announces Preliminary Unaudited 4Q19 Net Sales
5:25pm
8-K
EX-10.1
8mzm5e37r sov
7 Nov 19
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.2
okw4spy4
7 Nov 19
Entry into a Material Definitive Agreement
4:38pm
8-K/A
EX-99.1
t1ujz6vdnb 7pm
9 Aug 19
Sientra Reports Second Quarter 2019 Financial Results
4:25pm
8-K
EX-99.1
zgmf2k v4m2zm
8 Aug 19
Sientra Reports Second Quarter 2019 Financial Results
4:21pm
8-K
EX-1.1
i46469l s9f
5 Jun 19
Sientra Commences Public Offering of Common Stock
4:10pm
424B5
bh5heqile2f
5 Jun 19
Prospectus supplement for primary offering
4:03pm
424B5
bzo6g9 x6mt35d80z9
3 Jun 19
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
m7isn exjv4mcmi
21 Mar 19
Sientra® Issues Statement in Response to FDA Post-Approval Study Warning Letter
4:40pm